Long-term survival and late deaths after allogeneic hematopoietic cell transplantation

Journal of Clinical Oncology

Volumn 29, Issue 16, 2011, Pages 2230-2239

  Wingard, John R ^{a,b,c,d,e,f,g}   Majhail, Navneet S ^{a,b,c,d,e,f,g}   Brazauskas, Ruta ^{a,b,c,d,e,f,g}   Wang, Zhiwei ^{a,b,c,d,e,f,g}   Sobocinski, Kathleen A ^{a,b,c,d,e,f,g}   Jacobsohn, David ^{a,b,c,d,e,f,g}   Sorror, Mohamed L ^{a,b,c,d,e,f,g}   Horowitz, Mary M ^{a,b,c,d,e,f,g}   Bolwell, Brian ^{a,b,c,d,e,f,g}   Rizzo, J Douglas ^{a,b,c,d,e,f,g}   Socié, Gérard ^{a,b,c,d,e,f,g}  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

^g SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; MONOCLONAL ANTIBODY CD3; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BLEEDING; BURKITT LYMPHOMA; CANCER SURVIVAL; CELL TRANSPLANTATION; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; FOLLICULAR LYMPHOMA; FOLLOW UP; GENDER; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HODGKIN DISEASE; HUMAN; IMMUNOBLASTIC LYMPHOMA; INTERSTITIAL PNEUMONIA; LARGE CELL LYMPHOMA; LYMPHATIC LEUKEMIA; LYMPHOBLASTOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; MYELODYSPLASTIC SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; MIDDLE AGED; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 79957958325     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.33.7212     Document Type: Article

References (31)

1. Socié G, Stone JV, Wingard JR, et al: Longterm survival and late deaths after allogeneic bone marrow transplantation: Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 341:14-21, 1999
2. Clark TG, Altman DG, De Stavola BL: Quantification of the completeness of follow-up. Lancet 359:1309-1310, 2002 (Pubitemid 34310638)
3. Klein J, Moeschberger M: Survival Analysis: Techniques of censored and truncated data. (ed 2). New York, NY, Springer-Verlag, 2003
4. Andersen PK, Vaeth M: Simple parametric and nonparametric models for excess and relative mortality. Biometrics 45:523-535, 1989
5. Copelan E, Casper JT, Carter SL, et al: A scheme for defining cause of death and its application in the T cell depletion trial. Biol Blood Marrow Transplant 13:1469-1476, 2007 (Pubitemid 350091384)
6. Weisdorf D, Spellman S, Haagenson M, et al: Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: Revised definitions to predict survival. Biol Blood Marrow Transplant 14:748-758, 2008 (Pubitemid 351773151)
7. Martin PJ, Counts GW Jr, Appelbaum FR, et al: Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. J Clin Oncol 28:1011-1016, 2010
8. Bhatia S, Francisco L, Carter A, et al: Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: Report from the Bone Marrow Transplant Survivor Study. Blood 110:3784-3792, 2007 (Pubitemid 350159650)
9. Deeg HJ, Leisenring W, Storb R, et al: Longterm outcome after marrow transplantation for severe aplastic anemia. Blood 91:3637-3645, 1998 (Pubitemid 28225730)
10. Duell T, van Lint MT, Ljungman P, et al: Health and functional status of long-term survivors of bone marrow transplantation: EBMT Working Party on Late Effects and EULEP Study Group on Late Effects-European Group for Blood and Marrow Transplantation. Ann Intern Med 126:184-192, 1997
11. Goldman JM, Majhail NS, Klein JP, et al: Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase. J Clin Oncol 28:1888-1895, 2010
12. Pond GR, Lipton JH, Messner HA: Long-term survival after blood and marrow transplantation: Comparison with an age- and gender-matched normative population. Biol Blood Marrow Transplant 12:422-429, 2006 (Pubitemid 43380959)
13. Majhail NS, Bajorunaite R, Lazarus HM, et al: Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma. Br J Haematol 147:129-139, 2009
14. Majhail NS, Bajorunaite R, Lazarus HM, et al: High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR. Bone Marrow Transplant 46:385-392, 2011
15. Mertens AC, Liu Q, Neglia JP, et al: Causespecific late mortality among 5-year survivors of childhood cancer: The Childhood Cancer Survivor Study. J Natl Cancer Inst 100:1368-1379, 2008
16. Armstrong GT, Pan Z, Ness KK, et al: Temporal trends in cause-specific late mortality among 5-year survivors of childhood cancer. J Clin Oncol 28:1224-1231, 2010
17. MacArthur AC, Spinelli JJ, Rogers PC, et al: Mortality among 5-year survivors of cancer diagnosed during childhood or adolescence in British Columbia, Canada. Pediatr Blood Cancer 48:460-467, 2007 (Pubitemid 46340114)
18. Schiffer CA, Dodge R, Larson RA: Long-term follow-up of Cancer and Leukemia Group B studies in acute myeloid leukemia. Cancer 80:2210-2214, 1997 (Pubitemid 27509593)
19. Antin JH: Immune reconstitution: The major barrier to successful stem cell transplantation. Biol Blood Marrow Transplant 11:43-45, 2005
20. Tomblyn M, Chiller T, Einsele H, et al: Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: A global perspective. Biol Blood Marrow Transplant 15:1143-1238, 2009
21. Curtis RE, Travis LB, Rowlings PA, et al: Risk of lymphoproliferative disorders after bone marrow transplantation: A multi-institutional study. Blood 94:2208-2216, 1999 (Pubitemid 29467666)
22. Landgren O, Gilbert ES, Rizzo JD, et al: Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood 113:4992-5001, 2009
23. Krishnan A, Bhatia S, Slovak ML, et al: Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: An assessment of risk factors. Blood 95:1588-1593, 2000 (Pubitemid 30120817)
24. Metayer C, Curtis RE, Vose J, et al: Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: A multicenter case-control study. Blood 101:2015-2023, 2003 (Pubitemid 36237609)
25. Bhatia S, Louie AD, Bhatia R, et al: Solid cancers after bone marrow transplantation. J Clin Oncol 19:464-471, 2001 (Pubitemid 32112860)
26. Rizzo JD, Curtis RE, Socié G, et al: Solid cancers after allogeneic hematopoietic cell transplantation. Blood 113:1175-1183, 2009
27. Curtis RE, Metayer C, Rizzo JD, et al: Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stemcell transplantation: An international case-control study. Blood 105:3802-3811, 2005 (Pubitemid 40662691)
28. Curtis RE, Rowlings PA, Deeg HJ, et al: Solid cancers after bone marrow transplantation. N Engl J Med 336:897-904, 1997 (Pubitemid 27137189)
29. Rizzo JD, Wingard JR, Tichelli A, et al: Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: Joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 12:138-151, 2006 (Pubitemid 43138009)
30. Bishop MM, Lee SJ, Beaumont JL, et al: The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls. Biol Blood Marrow Transplant 16:207-214, 2010
31. Antin JH: Clinical practice: Long-term care after hematopoietic-cell transplantation in adults. N Engl J Med 347:36-42, 2002